|
Volumn 126, Issue 25-26, 2001, Pages 758-760
|
Currrent therapy of Sneddon's (antiphospholipid) syndrome;Aktuelle therapie des Sneddon-syndroms
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CAPTOPRIL;
PROSTAGLANDIN E1;
TICLOPIDINE;
ANTIPHOSPHOLIPID SYNDROME;
CELL MIGRATION;
CELL PROLIFERATION;
HEMOSTASIS;
PROGNOSIS;
REVIEW;
RISK FACTOR;
SNEDDON SYNDROME;
SUBENDOTHELIUM;
ALPROSTADIL;
ANTIHYPERTENSIVE AGENTS;
BLOOD CIRCULATION;
CAPTOPRIL;
FIBRINOLYTIC AGENTS;
HUMANS;
PROGNOSIS;
RISK FACTORS;
SMOKING;
SNEDDON SYNDROME;
TICLOPIDINE;
|
EID: 0035933414
PISSN: 00120472
EISSN: None
Source Type: Journal
DOI: 10.1055/s-2001-15095 Document Type: Review |
Times cited : (11)
|
References (16)
|